Found: 6
Select item for more details and to access through your institution.
Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.
- Published in:
- Rheumatology, 2013, v. 52, n. 9, p. 1731, doi. 10.1093/rheumatology/ket121
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article